-
Code of conduct
Aegean Conferences is committed to making its meetings an inclusive space for sharing ideas and knowledge. The code of conduct can be found at:https://www.aegeanconferences.org/src/App/pages/view/AegeanCodeofConduct
Accommodations
Accommodations for the conference are at the Sheraton Hotel. The Hotel is located in Ixia, Rhodes, 14.5 km from the airport.
Arrival and Check-in
Attendees are expected to arrive/check-in after 3:00 PM local time. Registered participants arriving after 10:00 PM should make alternative dinner arrangements.
Conference Venue
The Sheraton Conference Center is located at the hotel.
Handicapped Accessibility
The site is fully handicapped accessible.
Oral Presentations
Speakers are asked to bring their USB flash drive to the reception desk at least 30 minutes prior to the session. The allocated time for all presentations, unless otherwise indicated, includes five minutes Q&A.
City Tour
Buses for the city tour will depart from the hotel front lobby 3:00 PM. Badges are required for participation.
Breakfast
Breakfast for registered participants and registered accompanying persons will be served at the Sheraton Hotel main restaurant during the hours scheduled in this program.
Lunches/Informal Discussions
Lunches for registered participants and registered accompanying persons will be served during the times indicated in this program at the main restaurant. Badges are required for admission.
Dinners/Informal Discussions
Three of the dinners/informal discussions will be served during the times indicated in the program. Vegetarian entrees are available only upon request in advance of the meeting.
Internet, Phone, & Computer
Wireless internet access is available throughout the conference center free of charge during meeting hours.
Certificate of Participation
A Certificate of Participation will be distributed to a participant for those sessions that the participant has attended. A participant must attend an entire session to receive credit for that particular session. Late arrivals and early departures from a session will preclude a participant from receiving credit for that session.
Mask Recommendation
Face masks are recommended indoors.
No Photographs and Recording Devices
Participants are not allowed to photograph and/or record using cameras, mobile telephones and other recording devices during the slide and poster presentations.
Other Information
Animals are not permitted on site.
Badges are required for admission to all events.
All Aegean Conferences events are non-smoking.
Aegean Conferences expects attendees to conform their conduct at these meetings to the policies and procedures of their employing institution or company. If we learn of improper conduct by an attendee, we will take appropriate action, including reporting such conduct to the attendee's employing institution or company and barring the attendee from participation in our meetings.
The Aegean Conferences is committed to protecting the privacy of its visitors. Information that our meeting participants provide or that is derived from internal website tracking is not sold, rented or shared with any individual or organization. You can let us know that you would prefer not to receive information by e-mail at any time, simply by sending an e-mail to unsubscribe@aegeanconferences.org. If you do so, we will not use your personal information for informing you on our future meetings and other services.
Monday, September 26
06:00 PM - 07:00 PM
Conference Registration
07:00 PM - 10:00 PM
Welcome Reception and Dinner
Tuesday, September 27
07:30 AM - 09:00 AM
Breakfast
09:00 AM - 09:05 AM
Welcome and Opening Remarks - Kostas Coumenis
TME, Metastasis and Tumor Dormancy
Chairs: Costas Koumenis and Ashi Weeratna
09:05 AM - 09:30 AM
1
Age against the machine: how aging impacts tumor progressionAshani Weeraratna
09:30 AM - 09:55 AM
2
Origins and Behavior of Disseminated Tumor Cells during Minimal Residual Disease
Maria S Sosa, Carolina Rodriguez-Tirado, and Alcina A Rodrigues
09:55 AM - 10:20 AM
3
The Integrated Stress response in tumor progression and metastasis
Constantinos Koumenis
10:45 AM - 11:30 AM
4
Oxygen SensingWilliam Kaelin
11:10 AM - 12:00 PM
Coffee Break and Poster Viewing
12:00 PM - 12:25 PM
5
Regulation of the HIF response at the level of chromatinJames A Nathan
12:25 PM - 12:50 PM
6
The oncogenic role and therapeutic potential of targeting the RNA demethylase FTO in VHL deficient renal cell carcinoma.Man Zhao1, Dalin Zhang, Haowen Jiang1, Suchitra Natarajan1, Hongjuan Zhao, Jim Brooks, Donna Peehl, Amato Giaccia1,, and Erinn Bruno Rankin1
12:50 PM - 01:15 PM
7
Hypoxia-derived extracellular vesicles metabolically reprogram endothelial cells to induce angiogenesis Tom G Keulers, Joel E Beaumont, Kim R Kampen, and Kasper M Rouschop
01:15 PM - 02:45 PM
Lunch and Informal Discussions
02:45 PM - 07:00 PM
Informal Discussions
07:30 PM - 11:00 PM
Dinner and Informal Discussions (Buses Depart from Hotel Lobby)
Wednesday, September 28
07:30 AM - 08:30 AM
Breakfast
Therapeutic Targeting, Immune Evasion and Plasticity
08:30 AM - 08:55 AM
8
Novel Strategies for In-Situ Tumor Vaccination - Reprograming TIME Evolution via Compartmental Targeting Amir Abdollahi
08:55 AM - 09:20 AM
9
Optimizing the interaction between immunotherapy and treatments that both directly and indirectly target tumour cellsMichael R Horsman1, Priyanshu M Sinha1, Folefac C Asonganyi1, Søren Nygaard1, Mateusz K Sitarz2, Brita S Sørensen2, and Pernille B Elming1
09:20 AM - 09:45 AM
10
Mechanistic understanding of response and resistance to lysosomal inhibition Monika Bhardwaj 1, Jennifer J Lee1, Amanda Versace 1, Sandra L Harper 2, Aaron R Goldman 2, Mary Ann Crissey 1, Vaibhav Jain 1, Mahendra Rathore 1, megane vernon 3, Andrew E Aplin 3, Jeffrey D Winkler 1, Qin Liu 2, David W Speicher 2, and Ravi K Amaravadi 1
09:45 AM - 10:10 AM
11
Cell-extrinsic and –intrinsic mechanisms in pancreatic cancer subtype identity and therapy response
Niklas Krebs1, Lukas Klein1, Florian Wegwitz1, Elisa Espinet2, Carlo Maurer3, Mengyu Tu1, Frederike Penz1, Stefan Küffer4, Elisabeth Hessmann1, Andreas Trumpp2, Philipp Ströbel4, Rolf A Brekken5, Volker Ellenrieder1, and Shiv K Singh1
10:10 AM - 10:25 AM
12
Identification of a deubiquitination module essential for Treg fitness in the tumor microenvironmentDeyu Fang
10:25 AM - 11:10 AM
Coffee Break and Poster Viewing
11:10 AM - 11:35 AM
13
Hypoxia Tumour Biology and Tumour Genomics-CoDrivers of Tumour Evolution Robert Bristow
11:35 AM - 12:00 PM
14
Sensing aberrant transcription by MYC oncoproteinsDimtrios Papadopoulos, Daniel Solvie, Leonie Uhl, Stefanie Ha, and Martin Eilers
12:00 PM - 12:15 PM
15
Quantifying Poly(ADP-Ribose) Polymerase (PARP) in vivo using a non-invasive PARP1 PET tracerLilie Lin
12:15 PM - 12:40 PM
16
Nerve Growth Factor Regulation of the Gastric Cancer Tumor MicroenvironmentJin Cho, Xiaofei Zhi, Timothy C. Wang, and Sandra Ryeom
12:40 PM - 01:05 PM
17
Pathway analysis including miRNA functional analysis in tissue and cell type contexts
Artemis G. Hatzigeorgoiu
01:05 PM - 01:20 PM
18
Cancer-associated bacteria as a novel component of the tumor microenvironment affecting breast cancer proliferation, metabolism, and immunity Alana A Arnone, Yu-Ting Tsai, Adam S Wilson, David R Soto-Pantoja, and Katherine L Cook
01:20 PM - 01:40 PM
Special Session: Alexia-Ileana Zaromytidou, Nature Cancer Editor
01:40 PM - 03:00 PM
Lunch and Informal Discussions
03:00 PM - 06:30 PM
Informal Discussions
06:45 PM - 10:30 PM
Dinner and Informal Discussions (Buses depart from Hotel Lobby)
Thursday, September 29
07:30 AM - 08:30 AM
Breakfast
08:30 AM - 08:55 AM
19
Identifying a conserved molecular signature for pediatric osteosarcomaLinda M Hendershot
08:55 AM - 09:20 AM
20
Mechanisms and functions of eIF2 kinase GCN2 in translational control and stress adaptationRonald C Wek1 and Tracy G Anthony2
09:20 AM - 09:45 AM
21
Uncovering cross-talk between mediators of the Unfolded Protein ResponseGideon Ong, Wafa Kammouni, and Susan E Logue
09:45 AM - 10:10 AM
22
Prostate cancer is addicted to GCN2 to preserve amino acid homeostasisRicardo A. Cordova1, Jagannath Misra1, Tracy G. Anthony2, Roberto Pili3, Ronald C. Wek1, and Kirk A. Staschke1
10:10 AM - 10:35 AM
23
Microenvironmental and cancer cell intrinsic mechanisms of early dissemination reveal a new dormancy program and a vulnerability to target dormant cancer cells.Julio A Aguirre-Ghiso
10:35 AM - 11:20 AM
Coffee Break and Poster Viewing
Metabolism, Epigenetics and the TME
11:20 AM - 11:45 AM
24
Therapeutic vulnerabilities in cancer stemming from metabolic heterogeneityBen Stanger
11:45 AM - 12:10 PM
25
The drivers and effectors of phenotype switchingColin Goding
12:10 PM - 12:35 PM
26
KMT2C loss is associated with an aggressive tumor phenotype in bladder cancerApostolos Klinakis
12:35 PM - 01:00 PM
27
Phenotypic reprogramming of the prostate tumor microenvironment overcomes therapeutic resistanceNatasha Kyprianou and Maddison R. Archer
01:00 PM - 01:15 PM
28
Cancer cells depend on environmental lipids for proliferation when electron acceptors are limitedDennis Vitkup
01:15 PM - 02:45 PM
Lunch and Informal Discussions
03:00 PM - 07:30 PM
City Tour (Buses Depart from Hotel Lobby)
07:30 PM - 10:30 PM
Dinner and Informal Discussions (Buses do not return to the hotel prior to dinner)
Friday, September 30
07:30 AM - 08:30 AM
Breakfast
Radiation Resistance and Sensitization
08:30 AM - 08:55 AM
29
A phase II study of nelfinavir plus concurrent chemoradiation for advanced, HPV-negative squamous cell carcinoma of the head and neckWilliam Su1, Amit Maity1, Daniel Pryma2, David A Mankoff2, Roger B Cohen3, John N Lukens1, and Alexander Lin1
08:55 AM - 09:20 AM
30
Hypoxia-induced ROS leads to the accumulation of R-loops independently of DNA damage Ester M Hammond
09:20 AM - 09:45 AM
31
Radiation and immune-modulation in lung cancer: perspective from a clinical and translational lensRamesh Rengan
09:45 AM - 10:10 AM
32
Immune Priming using low energy focused ultrasound (LOFU) Chandan Guha
10:10 AM - 10:25 AM
33
Prediction of inter-fractional motion in lung cancer and impact on proton therapy deliveryKyriakos Fotiou and Eirik Malinel
10:25 AM - 11:20 AM
Coffee Break and Poster Viewing
Latest developments in Radiotherapy-FLASH Radiation
11:20 AM - 11:45 AM
34
Defining the future of FLASH radiation in the clinical settingJames M Metz
11:45 AM - 12:10 PM
35
Physics considerations for commissioning an experimental beam line for in vivo proton FLASH experimentsMichele Kim
12:10 PM - 12:35 PM
36
Mechanistic insights on the increased therapeutic index of FLASH abdominal irradiation in mice, and technological path to clinical translation of FLASH therapyBilly W Loo1, Erinn B Rankin1, Vignesh Viswanathan1, Stavros Melemenidis1, Rakesh Manjappa1, M Ramish Ashraf1, Luis Soto1, Suparna Dut1, Brendan Whelan2, Brianna Lau1, Murat Surucu1, Amy S Yu1, G-One Ahn4, Joel Greenberger5, Michael Epperly5, Kerriann Casey3, Edward E Graves1, Peter G Maxim6, and Sami G Tantawi7
12:35 PM - 01:00 PM
37
FLASH in murine and 3D spheroid models – Vancouver experienceAlastair Kyle1, Jennifer Baker1, Judit Banath1, Taixiang Wang1, Anam Liu1, Tania Karan2, Claudia Mendez2, Alanah Bergman2, Peter Petric2, Cheryl Duzenli2, and Andrew Minchinton1
01:00 PM - 01:10 PM
Closing Remarks: Ester Hammond
01:10 PM - 02:30 PM
Lunch and Informal Discussions
02:30 PM - 07:00 PM
Informal Discussions
07:30 PM - 11:00 PM
Farewell Dinner
Saturday, October 01
08:00 AM - 10:00 AM
Breakfast
10:00 AM - 12:00 PM
Departure